Bufferin and haematocrit decreased Patient Reports February 12, 2012

Bufferin Side Effects Report #5228270-0
Bufferin side effect was reported by a Physician from JAPAN on Jan 24, 2007. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction, gastric ulcer, diabetes mellitus, hypertension and was treated with Bufferin. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood glucose increased, blood lactate dehydrogenase increased, c-reactive protein increased, catheterisation cardiac, chest x-ray abnormal, cough, haematocrit decreased, haemoglobin decreased. Bufferin dosage: 162 MG/DAY. During the same period patient was treated with PANALDINE, OMEPRAL, EUGLUCON, DIOVAN, RENIVACE. Patient was hospitalized. Patient recovered.

Bufferin Side Effects Report #5181080-5
Bufferin side effect was reported by a Physician from JAPAN on Nov 21, 2006. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction, gastric ulcer, diabetes mellitus, hypertension and was treated with Bufferin. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood glucose increased, blood lactate dehydrogenase increased, c-reactive protein increased, catheterisation cardiac, chest x-ray abnormal, cough, haematocrit decreased, haemoglobin decreased. Bufferin dosage: 162 MG/DAY. During the same period patient was treated with PANALDINE, OMEPRAL, EUGLUCON, DIOVAN, RENIVACE. Patient was hospitalized. Patient recovered.

Bufferin Side Effects Report #5194700-6
Bufferin side effect was reported by a Physician from JAPAN on Nov 21, 2006. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction, gastric ulcer, diabetes mellitus, hypertension and was treated with Bufferin. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood glucose increased, blood lactate dehydrogenase increased, c-reactive protein increased, catheterisation cardiac, chest x-ray abnormal, cough, haematocrit decreased, haemoglobin decreased. Bufferin dosage: 162 MG/DAY. During the same period patient was treated with PANALDINE, OMEPRAL, EUGLUCON, DIOVAN, RENIVACE. Patient was hospitalized. Patient recovered.